A prime goal of ReSurfX is to disrupt the status quo to empower data and technology-intensive enterprises by incorporating novel data-source agnostic solutions through innovations outside the mainstream of standard analytics framework. ReSurfX::vysen 2.0 our is a rapidly evolving enterprise-grade, cloud-based, integrative analytics platform leveraging our novel and powerful 'Adaptive Hypersurface Technology (AHT)' to solve a variety of analytics problems focused on the life science and healthcare sectors. AHT helps organizations gain never before achieved levels of accuracy and novel insights, significantly improving ROI and innovation from data-analytics initiatives.
We are revolutionizing healthcare through novel and effective data utilization strategies to combine large scale measurement technologies (e.g., omics data) and data from healthcare settings (e.g., EHR). vysen is one component to deliver data-analytics to significantly improve life sciences discovery, drug development, healthcare outcomes and efficient delivery of high cost healthcare products
Technology and Product
Adaptive Hypersurface Technology (AHT) is a novel data-analytics concept based on adaptively identifying combinations of input parameters to determine outcome of interest. This novel and powerful comparative analytics approach leads to robust, sensitive and accurate outcomes. In customer data initiatives and on widely studied large datasets used as benchmark AHT yielded unprecedented levels of accuracy compared to other analytic approaches.
The current product, ReSurfX::vysen, leverages the superior advantages of AHT to gene expression analytics from sequencing and microarray and has repository scale processing capabilities with unique product structure and integration advantages.
vysen 2.0 adopts an attractive tiered pricing model that aligns cost for customers with their volume of data usage. We also offer a FREE TRIAL version to experience the product advantages and features.
Hybrid Solution Portfolio
We deploy a dual strategy to big data problems both through technology redesign solutions to remove fundamental errors at data generation step and decision analytic products for efficient downstream analytics. Our products and solutions offer tremendous advantages and applications in areas of Personalized Medicine, Clinical Trials, Drug Discovery and Development, Patient Care Decision etc.
ReSurfX::vysen 2.0 is just one component of our interlinked product line providing end-to-end value to life science and healthcare enterprises:
- Advance outcomes alert system for clinical trials, newer business models for pharmaceutical product sales and quantitative support for evidence-based medicine.
- Getting superior data to flow through enterprise workflows facilitating automated knowledge extraction, novel insights, and more efficient discovery and downstream business operations.
- Redesign of measurement systems that generate large volumes of data or of systems used in large volumes (e.g., sequencing scanners, physical and e-diagnostics) at both the sensor and component levels. ReSurfX sensor/component level technology redesign solutions improve the quality of data while simplifying data usage.
Click here to learn more about the vysen product
ReSurfX continues to garner recognition as a promising company bringing unique leading edge
value to the healthcare and life sciences industry.
We have been recognized with numerous accolades which include recognition as:
- One of '20 Most Promising Data Analytics Vendors 2017' by CIOReview magazine.
- An 'emerging company defining the next generation of personalized medicine platforms and technologies' by the Personalized Medicine World Congress (PMWC).